Fresenius SE Pre-Tax Profit Margin 2016-2023 | FSNUY

Current and historical pre-tax profit margin for Fresenius SE (FSNUY) from 2016 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Fresenius SE pre-tax profit margin for the three months ending September 30, 2023 was .
Fresenius SE Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2023-09-30 $39.20B $1.88B 4.79%
2023-06-30 $43.73B $2.36B 5.40%
2023-03-31 $43.10B $2.75B 6.37%
2022-12-31 $43.03B $2.97B 6.89%
2022-09-30 $43.53B $3.56B 8.17%
2022-06-30 $43.99B $3.85B 8.74%
2022-03-31 $44.47B $4.15B 9.34%
2021-12-31 $44.39B $4.32B 9.73%
2021-09-30 $44.08B $4.21B 9.56%
2021-06-30 $43.51B $4.30B 9.87%
2021-03-31 $42.19B $4.26B 10.11%
2020-12-31 $41.44B $4.26B 10.27%
2020-09-30 $40.66B $4.42B 10.87%
2020-06-30 $40.06B $4.36B 10.89%
2020-03-31 $40.09B $4.36B 10.88%
2019-12-31 $39.66B $4.38B 11.04%
2019-09-30 $39.42B $4.42B 11.21%
2019-06-30 $39.12B $4.40B 11.24%
2019-03-31 $39.27B $5.48B 13.94%
2018-12-31 $39.60B $5.51B 13.91%
2018-09-30 $39.76B $5.38B 13.52%
2018-06-30 $39.98B $5.45B 13.63%
2018-03-31 $39.37B $4.41B 11.21%
2017-12-31 $38.30B $4.45B 11.62%
2017-09-30 $36.47B $4.53B 12.41%
2017-06-30 $34.84B $4.45B 12.76%
2017-03-31 $33.47B $4.38B 13.10%
2016-12-31 $32.18B $4.14B 12.88%
2016-09-30 $31.71B $10.91B 34.41%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.537B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.695B 16.22
DaVita (DVA) United States $12.150B 15.09
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Amedisys (AMED) United States $3.145B 22.28
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00